# Mirogabalin for Total Hip Arthroplasty

> **NCT05938088** · NA · UNKNOWN · sponsor: **Gangnam Severance Hospital** · enrollment: 56 (estimated)

## Conditions studied

- Hip Osteoarthritis

## Interventions

- **DRUG:** Arm I (mirogabalin group)
- **DRUG:** Arm II (placebo group)

## Key facts

- **NCT ID:** NCT05938088
- **Lead sponsor:** Gangnam Severance Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-20
- **Primary completion:** 2025-06-28
- **Final completion:** 2025-06-28
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2023-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05938088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05938088, "Mirogabalin for Total Hip Arthroplasty". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05938088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*